Stardog's Enterprise Knowledge Graph platform delivers 320% ROI
Forrester determined an ROI of 320% and total benefits of over $9.86 million over three years for the Stardog Enterprise Knowledge Graph Platform.
Read this study to learn how several customers turned their data into knowledge, completed their data analytics projects faster, saved on infrastructure costs, and unlocked new business opportunities with Stardog.
3X faster development
Organizations reported that data analytics applications were completed two to three times faster with Stardog compared to alternative solutions.
$2.6 million in avoided infrastructure costs
Stardog contributed to lower data infrastructure costs - especially costs for the hardware to support data operations regarding storage and compute time.
$3.8 million in time savings for data scientists
Data scientists and data engineers using Stardog saw a 75%-95% time savings for their primary tasks like data gathering, data cleaning, model building, and querying.
$2.4 million in profit from incremental successful data analytics projects
Future data analytics projects are more likely to succeed after you deploy Stardog.
Deliver up to 320% ROI on your data
The ability to virtualize the graph was key. Virtualization and [Stardog’s] advanced analytics capabilities were two of the main reasons we chose them over [another semantic graph provider].”• Director of Analytics and Informatics, R&D and Business Technology, Pharmaceuticals
[The data collection process] went from months, to weeks, to days, to minutes—it’s almost unbelievable.”• Director of Informatics and Analytics, R&D and Business Technology, Pharmaceuticals
The knowledge graph exposes connections that are in the data but are difficult to see with relational databases.”• Executive Director of Technology, Finance
The [data scientists] tell us, ‘We’ve never seen data like that before. Can you do that again?’ And then they come back to us with another list of requests—the answer is, yes.”• Director of Analytics and Informatics, R&D and Business Technology, Pharmaceuticals